Researchers have used a new version of CRISPR to fix problems in RNA rather than to edit DNA, a promising step for a group of diseases that have no cure.
Researchers in the U.K. are developing an immunotherapy treatment for diabetes that has proven safe and effective in a small trial.
With pressures to fast-track clinical development, the pharmaceutical industry recognizes the value of improving internal clinical data management processes.…
The past week ushered in discoveries related to the genetics of immuno-oncology success, genes and heart failure, and treating Gulf War illness.
Scientists at Yale University believe they’ve discovered how lysosomes—the "garbage disposal" units in brain cells—contribute to Alzheimer’s.
An approved diabetes drug may change the progression of Parkinson's disease rather than just treating symptoms while the disease worsens.
Harvard University researchers have identified an enzyme that protects cells from harmful fats, which could inform new obesity treatments.
University of Michigan scientists made some surprising discoveries when they did a detailed genetic analysis of metastatic tumors from 500 patients.
The past week brought new discoveries in overeating and obesity, the genes that promote cancer and a new way to prevent sunburn.
Most progeria researchers focus on the genetic mutation that causes the disease, but a Houston Methodist team is targeting the shortening of telomeres.
A University of Missouri-led team developed a new gene transfer method to treat Duchenne muscular dystrophy.